Literature DB >> 11754415

Update on selected inherited venous thrombotic disorders.

R S Robetorye1, G M Rodgers.   

Abstract

The inherited thrombophilias are a group of inherited conditions that predispose to thrombotic events. Most of the inherited thrombotic disorders are associated with venous thromboembolism rather than arterial thrombosis. Frequently, one or more predisposing genetic factors and/or environmental risk factor are identified in thrombosis patients. Significant advances in the identification of etiologies of inherited thrombosis have recently been reported. The most common inherited thrombotic disorders include activated protein C (APC) resistance (factor V Leiden), hyperhomocysteinemia, the prothrombin gene variant G20210A, elevated factor VIII levels, and deficiencies of thrombomodulin, protein C, protein S, and antithrombin. Less well characterized disorders include elevated factor IX, X, and XI levels. Recognition of these disorders now permits a laboratory diagnosis in approximately 70% of patients being evaluated for inherited thrombosis. This review focuses on the clinical and laboratory aspects of some of the most common inherited venous thrombotic disorders, including APC resistance, hyperhomocysteinemia, the prothrombin G20210A mutation, and elevated coagulation factor levels. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11754415     DOI: 10.1002/ajh.10002

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  5 in total

1.  Cystatin C is associated with risk of venous thromboembolism in subjects with normal kidney function--the Tromsø study.

Authors:  Ellen E Brodin; Sigrid K Brækkan; Anders Vik; Jan Brox; John-Bjarne Hansen
Journal:  Haematologica       Date:  2012-02-07       Impact factor: 9.941

2.  Physical activity and risk of venous thromboembolism. The Tromso study.

Authors:  Knut H Borch; Ida Hansen-Krone; Sigrid K Braekkan; Ellisiv B Mathiesen; Inger Njolstad; Tom Wilsgaard; John-Bjarne Hansen
Journal:  Haematologica       Date:  2010-08-26       Impact factor: 9.941

Review 3.  [Mechanisms of action of recombinant human activated Protein C].

Authors:  M Brueckmann; G Huhle; M Max
Journal:  Anaesthesist       Date:  2006-06       Impact factor: 1.041

4.  Testing for hereditary thrombophilia: a retrospective analysis of testing referred to a national laboratory.

Authors:  Brian R Jackson; Kyland Holmes; Amit Phansalkar; George M Rodgers
Journal:  BMC Clin Pathol       Date:  2008-04-02

5.  Risk factors for deep vein thrombosis of lower extremities in Sudanese women.

Authors:  Nadir Ahmed Ibrahim; Fathelrahman M Hassan; Mahmoud Mohamed Elgari; Sana Eltahir Abdalla
Journal:  Vasc Health Risk Manag       Date:  2018-08-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.